Application no. and date | 11730112.7 (espacenet) (Federated) (European Patent Register), 20110311 | Patent/reg. no. and date | DK/EP 2544680, 20150114 | Publication date | 20130116 | Priority no. and date | US 312895 P, 20100311 | EP pub. no. and date |
EP 2544680 20130116 | Effective date | | Applicant/owner | Merrimack Pharmaceuticals, Inc., One Kendall Square Suite B7201
Cambridge, MA 02139, US | Applicant ref. no. | P015922EPDK1 EJ/GB | Inventor | GARCIA, Gabriela, 14 Knoll St.
Roslindale, MA 02131, US, MOYO, Victor, 1694 Main Street, Apt. 5
Concord, MA 01742, US | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | Opponent | | IPC Class | A61K 31/337 (2006.01) , A61K 31/517 (2006.01) , A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) , C07K 16/30 (2006.01) , C07K 16/32 (2006.01) | Title | ANVENDELSE AF ERBB3-HÆMMERE I BEHANDLINGEN AF TRIPLE-NEGATIV BRYSTCANCER | Int. application no. | US2011028129 | Int. publication no. | WO2011112953 | Related patent (certificate) | | Status | Ophævet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|